Hologic Inc (FRA:HO1)
€ 68.5 0 (0%) Market Cap: 16.11 Bil Enterprise Value: 16.47 Bil PE Ratio: 38.24 PB Ratio: 3.63 GF Score: 81/100

Hologic Inc at RBC Capital Markets Healthcare Conference Transcript

May 21, 2019 / 12:30PM GMT
Release Date Price: €39.88 (+1.35%)
Brandon Christopher Henry
RBC Capital Markets, LLC, Research Division - Analyst

We're going to start next session. My name is Brandon Henry, and I'm the medical device analyst here at RBC. On stage with me is Mike Watts, VP of Investor Relations and Corporate Communication. So Mike, thank you for joining us.

Michael J. Watts
Hologic, Inc. - VP of IR & Corporate Communications

Thanks for having us.

Brandon Christopher Henry
RBC Capital Markets, LLC, Research Division - Analyst

I think you wanted to start out with a brief kind of 2, 3 minute introduction and then we'll jump into Q&A.

Michael J. Watts
Hologic, Inc. - VP of IR & Corporate Communications

Yes, Sure. So thanks to you and to RBC for hosting us. We appreciate it. Do see some new faces in the room, so let me spend a couple of minutes and just give a brief overview of Hologic to level set us. We are an innovative medical device company. We're primarily focused on improving women's health through

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot